444 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
Mathieu Gigoux, Roberta Zappasodi, Joseph Park, Stephane Pourpe, Arnab Ghosh, Cansu Cimen Bozkus, Levi Mangarin, David Redmond, Svena Verma, Sara Schad, William Duke, Max Jan, Matthew Leventhal, Vincent Ho, Gabriela Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Hasselbalch, Jacob Grauslund, Mads Andersen, Morten Holmström, Timothy Chan, Raajit Rampal, Omar Abdel-Wahab, Nina Bhardwaj, Jedd Wolchok, Ann Mullally, Taha Merghoub
Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A270; DOI: 10.1136/jitc-2020-SITC2020.0444